NXTM : Summary for NxStage Medical, Inc. - Yahoo Finance

U.S. Markets open in 8 hrs 29 mins

Nxstage Medical, Inc. (NXTM)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
26.30-1.71 (-6.10%)
At close: 4:00PM EST
People also watch
PODDOFIXNUVAATRCWMGI
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close28.01
Open0.00
Bid0.00 x
Ask0.00 x
Day's Range26.26 - 27.91
52 Week Range13.49 - 28.36
Volume914,487
Avg. Volume400,982
Market Cap1.7B
Beta0.17
PE Ratio (TTM)-289.01
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube11 hours ago

    ETFs with exposure to NxStage Medical, Inc. : January 19, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to NxStage Medical, Inc. Here are 5 ETFs with the largest exposure to NXTM-US. Comparing the performance and risk of NxStage Medical, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • PR Newswire4 days ago

    NxStage® to Report Fourth Quarter and Full Year 2016 Financial Results

    LAWRENCE, Mass., Jan. 16, 2017 /PRNewswire/ -- NxStage Medical, Inc . (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care , today announced plans to release its financial ...

  • Hologic (HOLX) Receives PMA for Aptima HIV-1 Quant Assay
    Zacks16 days ago

    Hologic (HOLX) Receives PMA for Aptima HIV-1 Quant Assay

    Hologic, Inc. (HOLX) recently announced the receipt of the FDAs Premarket Approval (PMA) for its Aptima HIV-1 Quant assay.